Jianmin Pharmaceutical Group Co Ltd (600976) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.039x

Based on the latest financial reports, Jianmin Pharmaceutical Group Co Ltd (600976) has a cash flow conversion efficiency ratio of 0.039x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥106.82 Million ≈ $15.63 Million USD) by net assets (CN¥2.72 Billion ≈ $398.20 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600976 market cap overview for the company's overall valuation and market capitalisation.

Jianmin Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Jianmin Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Jianmin Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jianmin Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore Jianmin Pharmaceutical Group Co Ltd cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Skandinaviska Enskilda Banken AB (publ) ST:SEB-C	1.189x
Beijing Career International Co Ltd SHE:300662	0.059x
GMR Solutions Inc. NYSE:GMRS	0.605x
Guangdong Green Precision Components Co. Ltd. SHE:300968	-0.033x
Spearhead Integrated Marketing SHE:300071	-0.011x
Crescent Biopharma, Inc. NASDAQ:CBIO	-0.119x
Changchun Gas Co Ltd SHG:600333	-0.006x
Shandong Luyang Share Co Ltd SHE:002088	0.000x

Annual Cash Flow Conversion Efficiency for Jianmin Pharmaceutical Group Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Jianmin Pharmaceutical Group Co Ltd from 2003 to 2025. View 600976 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.72 Billion ≈ $398.20 Million	CN¥274.53 Million ≈ $40.17 Million	0.101x	+5.52%
2024-12-31	CN¥2.45 Billion ≈ $358.56 Million	CN¥234.27 Million ≈ $34.28 Million	0.096x	-19.62%
2023-12-31	CN¥2.26 Billion ≈ $330.19 Million	CN¥268.39 Million ≈ $39.27 Million	0.119x	+2.92%
2022-12-31	CN¥1.87 Billion ≈ $273.32 Million	CN¥215.87 Million ≈ $31.59 Million	0.116x	-30.07%
2021-12-31	CN¥1.57 Billion ≈ $229.48 Million	CN¥259.18 Million ≈ $37.93 Million	0.165x	+74.20%
2020-12-31	CN¥1.32 Billion ≈ $193.63 Million	CN¥125.54 Million ≈ $18.37 Million	0.095x	+53.92%
2019-12-31	CN¥1.21 Billion ≈ $176.76 Million	CN¥74.45 Million ≈ $10.89 Million	0.062x	+10.97%
2018-12-31	CN¥1.15 Billion ≈ $167.56 Million	CN¥63.60 Million ≈ $9.31 Million	0.056x	+74.75%
2017-12-31	CN¥1.11 Billion ≈ $162.05 Million	CN¥35.20 Million ≈ $5.15 Million	0.032x	-71.21%
2016-12-31	CN¥1.03 Billion ≈ $150.92 Million	CN¥113.84 Million ≈ $16.66 Million	0.110x	+127.22%
2015-12-31	CN¥997.36 Million ≈ $145.94 Million	CN¥48.45 Million ≈ $7.09 Million	0.049x	-52.85%
2014-12-31	CN¥1.00 Billion ≈ $146.63 Million	CN¥103.23 Million ≈ $15.11 Million	0.103x	+113.60%
2013-12-31	CN¥940.46 Million ≈ $137.62 Million	CN¥45.36 Million ≈ $6.64 Million	0.048x	-55.63%
2012-12-31	CN¥903.10 Million ≈ $132.15 Million	CN¥98.17 Million ≈ $14.37 Million	0.109x	+226.20%
2011-12-31	CN¥876.97 Million ≈ $128.33 Million	CN¥-75.54 Million ≈ $-11.05 Million	-0.086x	-148.72%
2010-12-31	CN¥848.81 Million ≈ $124.21 Million	CN¥150.08 Million ≈ $21.96 Million	0.177x	+117.47%
2009-12-31	CN¥820.32 Million ≈ $120.04 Million	CN¥66.69 Million ≈ $9.76 Million	0.081x	-43.79%
2008-12-31	CN¥761.24 Million ≈ $111.39 Million	CN¥110.11 Million ≈ $16.11 Million	0.145x	+1660.69%
2007-12-31	CN¥742.63 Million ≈ $108.67 Million	CN¥-6.88 Million ≈ $-1.01 Million	-0.009x	-112.65%
2006-12-31	CN¥766.61 Million ≈ $112.18 Million	CN¥56.18 Million ≈ $8.22 Million	0.073x	+260.73%
2005-12-31	CN¥759.65 Million ≈ $111.16 Million	CN¥-34.63 Million ≈ $-5.07 Million	-0.046x	-877.87%
2004-12-31	CN¥705.12 Million ≈ $103.18 Million	CN¥4.13 Million ≈ $604.74K	0.006x	-59.37%
2003-12-31	CN¥290.32 Million ≈ $42.48 Million	CN¥4.19 Million ≈ $612.80K	0.014x	--

About Jianmin Pharmaceutical Group Co Ltd

SHG:600976 China Drug Manufacturers - Specialty & Generic

Market Cap

$610.78 Million

CN¥4.17 Billion CNY

Market Cap Rank

#11400 Global

#3234 in China

Share Price

CN¥27.21

Change (1 day)

-1.34%

52-Week Range

CN¥24.91 - CN¥40.68

All Time High

CN¥83.88